The Silicon Valley Stock Board

[StockDetective]

Thanks for sharing Sloan. Very Interesting my friend.

[Sloan89RH]

Senator Moran's announcement last July

Sen. Moran Introduces Allergy Testing Access Act of 2019

See News Release:
https://www.moran.senate.gov/public/index.cfm/news-releases?ID=F30DCF13-1CC5-43FE-B9EF-246D2D01CC41

[Sloan89RH]

Senate Bill on Allergy Testing

S.2246 - Allergy Testing Access Act of 2019

The U.S. Senate bill (link below) sponsored by Sen. Jerry Moran [R-KS] (Introduced 07/24/2019) is working its way through the Senate process. When enacted it may prove beneficial to Arrayit.

https://www.congress.gov/bill/116th-congress/senate-bill/2246

[StockDetective]

Thanks for the link Sloan.

Looking at the growing amount of marketing partnerships & clinics makes me believe that demand is very high. Arrayit may currently be seeking additional CLIA laboratories to meet this demand.

https://www.gofundme.com/f/building-lab-for-humanitarian-allergy-treatment

2019 must have been a great year.

https://www.bizapedia.com/us/pediatric-allergy-solutions-llc.html

https://m.facebook.com/Pediatricallergysolutions/

https://storage.googleapis.com/wzukusers/user-27922100/documents/5be9c697a0feacHGfCzT/01)%20PAS%20-%20Sales%20-%20Sample%20Report%20-%20110118-2.pdf

[Sloan89RH]

One would think that with the FDA approval of Palforzia to treat peanut allergies in children that there would be an increased awareness of the need to have children tested through the Arrayit finger stick technology.

[Sloan89RH]

Thanks for the link. I've pasted the FDA announcement below:
https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treatment-peanut-allergy-children

[Sloan89RH]

Amarantus (AMBS) Investment Summary

Note the 31.5% ownership of Avant

• Biopharmaceutical Incubator Holding Company w/equity position in subsidiaries
o Elto Pharma (50.1%): Phase 2b/3-ready Adult ADHD drug candidate w/Ph2 data in Parkinson’s & Alzheimer’s
o Cutanogen (90.1%): Phase 3-ready Pediatric Severe Burn cell therapy candidate w/Phase 2 Data in GCMN
o MANF Tx (100%): Preclinical Vision Loss protein drug candidate w/multiple orphan drug opportunities
o Breakthrough Dx (80.01%): CLIA-ready Alzheimer’s blood test w/potential to diagnose CTE in life
o Avant Dx (31.5%): CLIA-ready Tumor Analysis Assay w/novel data input to optimize treatment selection
o Hempori (50.1%): CBD Wellness Company with storefronts in Dallas, TX
• Partnerships to Fund Product Development & Commercialization
o Emerald Organic Products (OTC: EMOR): License of Elto Pharma, Cutanogen and MANF Tx Assets
o Todos Medical (OTC:TOMDF): Acquisition of Breakthrough Dx
o Avant Diagnostics: Seasoned Management & Board driving Theralink commercialization forward
• Recapitalization Provides Opportunity to Invest at Attractive Valuation
o $50M+ raised to date to acquire and develop product candidate portfolio
o $16M remaining debt exchanging to Preferred Stock upon closing of Reg A
o Attractive opportunities for growth with Hempori

[DDStocks]

FDA approves first every peanut allergy pill

https://www.nbcphiladelphia.com/news/national-international/fda-approves-first-treatment-for-kids-with-peanut-allergy/2284512/

1.2 million people with peanut allergy

[StockDetective]

Nice! Thanks PSA!!

[BBstocks77]

Very interesting to hear about this. And like you or someone said in the past it would make sense that Avant work together with Arrayit on a mutually beneficial CLIA lab.

[BBstocks77]

Thanks PSA -definitely worthwhile having a board for Silicon Valley stocks - such as my favorite Arrayit:) Hard to beat the risk/reward we are looking at here.

[Sloan89RH]

Amarantus BioScience, Avant Diagnostics, and Arrayit

About four years ago I did research into Amarantus BioScience which originated in Silicon Valley but is now headquartered in New York. Through Amarantus I learned about Avant and Arrayit because they were partners with Amarantus on several initatives. Although Avant is not currently trading it is still active as one can see from the Power Point presentation below. In fact Avant is looking to establish a CLIA laboratory and there may be some synergies with Arrayit as it expands its lab presence to meet demand for its products. The presentation below was just released and is an update from an investor briefing prepared in December. I'm encouraged because Arrayit still has partial ownership in Avant.

https://content.equisolve.net/_2e49b9046905dc8bd8621a37fff66b80/amarantus/db/184/1122/pdf/AMBS+-+HoldCo+Presentation+February+2020+FINAL+Updated.pdf

[techmover]

Yep, I agree on that one completely!

[PennyStock Alert]

I have a busy afternoon but I’m looking forward to an open discussion here .....finally

[DDStocks]

Let’s try this again...

[HighYieldStocks]

Pro-minder's board...nice...here we go

[techmover]

OK. Thanks PSA.

[millionaireonpaper]

Will do...

[millionaireonpaper]

Thanks for your reply PSA.

[PennyStock Alert]

Good to see you. The other board was shut down because it was a secondary board to ARYC. It violated iHub rules unfortunately. This is an open board with a prim focus on one stock at a time and the current stock is ARYC. Feel free to post whatever is on your mind here.

[millionaireonpaper]

Hi guys, anyone care to explain what happened at the other board...I know there's not a lot going on but it's very quiet today.

[ScorpGirl]

Glad to find this board. Lots of exciting news to discuss in the SV. :)